The Allplex 2019-nCoV (Seegene) assay: which performances are for SARS-CoV-2 infection diagnosis?Éric Farfour, Marc Vasse, Philippe Lesprit et al.|European Journal of Clinical Microbiology & Infectious Diseases|2020Cited by 74
Interest of the cellular population data analysis as an aid in the early diagnosis of SARS‐CoV‐2 infectionMarc Vasse, Éric Farfour, Marie‐Christine Ballester et al.|International Journal of Laboratory Hematology|2020Cited by 23
The ID NOW COVID-19, a high-speed high-performance assayÉric Farfour, C Amiel, David Zucman et al.|European Journal of Clinical Microbiology & Infectious Diseases|2021Cited by 16
Improved performances of the second generation of the ID NOW influenza A&B 2® and comparison with the GeneXpert®Éric Farfour, Marc Vasse, Antoine Roux et al.|European Journal of Clinical Microbiology & Infectious Diseases|2020Cited by 13
Trends in ceftazidime‐avibactam activity against multidrug‐resistant organisms recovered from respiratory samples of cystic fibrosis patientsÉric Farfour, Philippe Lesprit, Erwan Trochu et al.|Transplant Infectious Disease|2018Cited by 12